Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
Magnani CF, Gaipa G, Lussana F, Belotti D, Gritti G, Napolitano S, Matera G, Cabiati B, Buracchi C, Borleri G, Fazio G, Zaninelli S, Tettamanti S, Cesana S, Colombo V, Quaroni M, Cazzaniga G, Rovelli A, Biagi E, Galimberti S, Calabria A, Benedicenti F, Montini E, Ferrari S, Introna M, Balduzzi A, Valsecchi MG, Dastoli G, Rambaldi A, Biondi A.
Magnani CF, et al. Among authors: biagi e.
J Clin Invest. 2020 Nov 2;130(11):6021-6033. doi: 10.1172/JCI138473.
J Clin Invest. 2020.
PMID: 32780725
Free PMC article.
Clinical Trial.